Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Inspirna has raised $55.1M in total funding. The most recent round was Series D. The last funding was announced in July 2022.
Inspirna's investors include Vivo Capital, Sands Capital Ventures, Novo Holdings, Sofinnova Partners, WuXi AppTec.
Inspirna is headquartered in New York, United States.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Inspirna is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inspirna — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/inspirna. Accessed September 14, 2026.
VCBacked. (2022). Inspirna — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/inspirna
{{cite web |title=Inspirna — Funding & Investors |url=https://www.vcbacked.co/company/inspirna |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated